Caxton Associates (New York)’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-18,807	Closed	-$306K	–	613
2024 Q1	$306K	Buy	+18,807	New	+$306K	0.02%	381
2023 Q2	–	Sell	-43,046	Closed	-$216K	–	669
2023 Q1	$216K	Buy	+43,046	New	+$216K	0.03%	403